Company profile for SIFI

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. SIFI started in 1935 as a venture specializing in the preparation of ophthalmic products. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide in June 2015, SIFI is bac...
Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. SIFI started in 1935 as a venture specializing in the preparation of ophthalmic products. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide in June 2015, SIFI is backed by 21 Invest, a private equity firm founded by Alessandro Benetton.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Aci Sant’Antonio
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sifi-merges-into-faes-farma-to-become-its-ophthalmic-franchise-and-expand-international-access-to-its-portfolio-and-pipeline-302477967.html

PR NEWSWIRE
10 Jun 2025

https://www.prnewswire.com/news-releases/sifi-receives-marketing-authorisation-and-promising-innovative-medicine-designation-for-akantior-in-the-uk-302458363.html

PR NEWSWIRE
19 May 2025

https://www.prnewswire.com/news-releases/sifi-announces-collaboration-with-the-university-of-california-san-francisco-on-acanthamoeba-keratitis-302403572.html

PR NEWSWIRE
18 Mar 2025

https://www.prnewswire.com/news-releases/sifi-provides-updates-on-the-uk-and-us-regulatory-pathways-for-akantior-in-the-treatment-of-acanthamoeba-keratitis-302331607.html

PR NEWSWIRE
16 Dec 2024

https://www.ema.europa.eu/en/documents/overview/akantior-epar-medicine-overview_en.pdf

EMA
29 Nov 2024

https://www.prnewswire.com/news-releases/sifi-announces-allowance-of-patent-on-polihexanide-for-europe-and-commercial-launch-of-akantior-in-germany-302260004.html

PR NEWSWIRE
30 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty